ALK-Abelló A/S
ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for th… Read more
ALK-Abelló A/S (AKBLF) - Total Liabilities
Latest total liabilities as of September 2025: $2.30 Billion USD
Based on the latest financial reports, ALK-Abelló A/S (AKBLF) has total liabilities worth $2.30 Billion USD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
ALK-Abelló A/S - Total Liabilities Trend (2005–2024)
This chart illustrates how ALK-Abelló A/S's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
ALK-Abelló A/S Competitors by Total Liabilities
The table below lists competitors of ALK-Abelló A/S ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Banco del Bajío S.A. Institución de Banca Múltiple
PINK:BBAJF
|
USA | $327.65 Billion |
|
21Vianet Group Inc
F:217A
|
Germany | €35.76 Billion |
|
InPost S.A
PINK:INPOF
|
USA | $13.48 Billion |
|
Ultra Clean Holdings Inc
NASDAQ:UCTT
|
USA | $944.90 Million |
|
Thai Beverage Public Company Limited
PINK:TBVPF
|
USA | $304.21 Billion |
|
Pangang Group Vanadium Titanium & Resources Co Ltd
SHE:000629
|
China | CN¥2.11 Billion |
Liability Composition Analysis (2005–2024)
This chart breaks down ALK-Abelló A/S's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.56 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.37 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.27 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how ALK-Abelló A/S's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for ALK-Abelló A/S (2005–2024)
The table below shows the annual total liabilities of ALK-Abelló A/S from 2005 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $2.87 Billion | +26.06% |
| 2023-12-31 | $2.28 Billion | -1.77% |
| 2022-12-31 | $2.32 Billion | -1.28% |
| 2021-12-31 | $2.35 Billion | -2.49% |
| 2020-12-31 | $2.41 Billion | +3.92% |
| 2019-12-31 | $2.32 Billion | +37.54% |
| 2018-12-31 | $1.69 Billion | +1.08% |
| 2017-12-31 | $1.67 Billion | -13.31% |
| 2016-12-31 | $1.92 Billion | +23.73% |
| 2015-12-31 | $1.55 Billion | +46.01% |
| 2014-12-31 | $1.06 Billion | +4.51% |
| 2013-12-31 | $1.02 Billion | +2.10% |
| 2012-12-31 | $998.00 Million | -15.92% |
| 2011-12-31 | $1.19 Billion | +46.18% |
| 2010-12-31 | $812.00 Million | +12.00% |
| 2009-12-31 | $725.00 Million | +7.25% |
| 2008-12-31 | $676.00 Million | -4.65% |
| 2007-12-31 | $709.00 Million | +2.01% |
| 2006-12-31 | $695.00 Million | -1.70% |
| 2005-12-31 | $707.00 Million | -- |